Regina Jones-Seamon

Rare disease state with PBC and Livdelzi, developing the market in second-line therapy.

• Collaborated with multidisciplinary teams to optimize patient treatment pathways.
• Regional Trainer-Trained and mentored junior staff on best practices in therapeutic approaches.
• Facilitated workshops for healthcare professionals on emerging therapeutic techniques.
• Developed strategies to address barriers to care, ensuring all patients had access to necessary treatments and resources.
• Hepatitis C test, treat and cure with Epclusa

• Selling Vivitrol (injectable naltrexone); Specialty, Hospital, Addiction medicine, treatment centers, FQHCs,Academic Institutions(WVU,Marshall, CAMC)
• Increased carton sales growth by 140% in first year
• Hit 116% goal in first quarter
• Team collaboration, individual sales territory
• Formulated Vivitrol in all Regional Jails in WV
• Finished 2019 in top 20% Vivitrol sales in Nation, ranked 11/90 in 2018
• Helped clients transcend addiction and rebuild lives by empowering each with knowledge and skills, as a Territory Business Manager
• Demonstrated leadership by making improvements to work processes and helping to train others, as a Field Based Trainer
• Lead several Regional and National Sales Meeting breakouts, New Hire Training and Mentorships
• Promote and facilitate buy and bill process

• Victoza,Levemir-Launched Saxenda and Tresiba
• Launched a new product/injectable device for obesity and a new basal insulin
• Ranked in top 14% of company in sales
• Launched new basal insulin in 2016-Tresiba
• Exceeded projected goal by 110% within 3 months of new product launch, finished in top 25% for 2015
• Promoted from DCS 2 to DCS 3 within 6 months.

• Successfully LAUNCHED: LINZESS, Lexapro, Fetzima, Viibryd, Namenda, Savella, Bystolic
• Marketed to GASTROENTEROLOGISTS
• Regional Rep of the QTR: 4th Qtr FY2005, 2nd Qtr FY2006, 3rd Qtr FY2007, 1st Qtr FY2008
• Assisted Beckley team to win PRESIDENTS CLUB in FY 2005
• Target customers: GI, OB/GYN, FP, Psych, Neurology in Hospital and Private-CNS sales
• Maintained top 20% sales in organization
• Earned Professional Representative status at year one, Medical Rep at second year
• Leader in Namenda goal attainment in first year of launch
• Led Savella with a 209% market share growth in its first year of launch
• 15 in the nation for converting Celexa to Lexapro Share in 2004

• Responsible for the hiring, promoting, training and termination of 6 offices and over 30 employees.